Agios Pharmaceuticals IncNASDAQ:AGIO
- LAST PRICE55.5800
- TODAY'S CHANGE (%)0.9600 (1.7576%)
- Bid / Lots54.0000/ 4
- Ask / Lots60.9500/ 23
- Open / Previous Close55.0000 / 54.6200
- Day Range
- 52 Week Range
- Volume368,873
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AGIO |
|---|---|---|
| 09:32 ET | 3633 | 54.69 |
| 09:33 ET | 600 | 55.24 |
| 09:35 ET | 973 | 54.2397 |
| 09:37 ET | 1245 | 54.75 |
| 09:39 ET | 804 | 54.82 |
| 09:44 ET | 100 | 55.055 |
| 09:48 ET | 100 | 55.09 |
| 09:50 ET | 200 | 55.23 |
| 09:51 ET | 993 | 54.895 |
| 09:53 ET | 1000 | 55.065 |
| 09:55 ET | 200 | 55.01 |
| 10:00 ET | 1303 | 54.7 |
| 10:02 ET | 693 | 54.82 |
| 10:04 ET | 800 | 54.445 |
| 10:08 ET | 100 | 54.375 |
| 10:09 ET | 800 | 54.32 |
| 10:11 ET | 100 | 54.44 |
| 10:13 ET | 300 | 54.47 |
| 10:15 ET | 668 | 54.395 |
| 10:18 ET | 100 | 54.395 |
| 10:20 ET | 1700 | 54.64 |
| 10:22 ET | 200 | 54.47 |
| 10:26 ET | 100 | 54.28 |
| 10:27 ET | 299 | 54.39 |
| 10:29 ET | 600 | 54.165 |
| 10:33 ET | 400 | 54.16 |
| 10:36 ET | 1360 | 54.23 |
| 10:38 ET | 2991 | 54.16 |
| 10:40 ET | 1029 | 53.99 |
| 10:42 ET | 1518 | 53.99 |
| 10:44 ET | 1472 | 54.005 |
| 10:45 ET | 3484 | 54 |
| 10:47 ET | 1769 | 54.015 |
| 10:49 ET | 3200 | 54.055 |
| 10:51 ET | 100 | 54.03 |
| 10:54 ET | 2626 | 54.22 |
| 10:56 ET | 884 | 54.36 |
| 10:58 ET | 400 | 54.42 |
| 11:00 ET | 729 | 54.42 |
| 11:02 ET | 600 | 54.415 |
| 11:03 ET | 1000 | 54.19 |
| 11:05 ET | 1515 | 54.255 |
| 11:07 ET | 500 | 54.24 |
| 11:09 ET | 600 | 54.19 |
| 11:12 ET | 400 | 54.135 |
| 11:14 ET | 500 | 54.15 |
| 11:16 ET | 500 | 54.2 |
| 11:18 ET | 701 | 54.1 |
| 11:20 ET | 5433 | 54.28 |
| 11:21 ET | 400 | 54.18 |
| 11:23 ET | 500 | 54.25 |
| 11:25 ET | 300 | 54.18 |
| 11:27 ET | 202 | 54.13 |
| 11:30 ET | 834 | 54.36 |
| 11:32 ET | 200 | 54.45 |
| 11:34 ET | 200 | 54.45 |
| 11:36 ET | 1819 | 54.85 |
| 11:38 ET | 400 | 54.72 |
| 11:39 ET | 500 | 54.72 |
| 11:41 ET | 600 | 54.68 |
| 11:43 ET | 100 | 54.62 |
| 11:48 ET | 300 | 54.69 |
| 11:50 ET | 300 | 54.79 |
| 11:54 ET | 100 | 54.785 |
| 11:56 ET | 1100 | 54.91 |
| 11:57 ET | 100 | 54.97 |
| 11:59 ET | 800 | 55.18 |
| 12:01 ET | 100 | 55.16 |
| 12:03 ET | 300 | 55.108 |
| 12:06 ET | 985 | 55.01 |
| 12:08 ET | 600 | 55.16 |
| 12:10 ET | 300 | 55.16 |
| 12:12 ET | 4406 | 55.43 |
| 12:14 ET | 400 | 55.35 |
| 12:15 ET | 1147 | 55.35 |
| 12:17 ET | 500 | 55.42 |
| 12:19 ET | 800 | 55.48 |
| 12:26 ET | 2122 | 55.39 |
| 12:28 ET | 1198 | 55.23 |
| 12:30 ET | 1200 | 55.45 |
| 12:32 ET | 200 | 55.385 |
| 12:33 ET | 100 | 55.45 |
| 12:35 ET | 300 | 55.41 |
| 12:37 ET | 752 | 55.395 |
| 12:39 ET | 1162 | 55.52 |
| 12:42 ET | 500 | 55.5 |
| 12:44 ET | 788 | 55.7 |
| 12:46 ET | 657 | 55.8 |
| 12:48 ET | 510 | 55.805 |
| 12:51 ET | 400 | 55.805 |
| 12:53 ET | 500 | 55.74 |
| 12:55 ET | 400 | 55.87 |
| 12:57 ET | 700 | 55.9415 |
| 01:00 ET | 300 | 55.855 |
| 01:02 ET | 800 | 55.805 |
| 01:04 ET | 1126 | 55.805 |
| 01:06 ET | 1344 | 55.95 |
| 01:08 ET | 100 | 55.8725 |
| 01:09 ET | 737 | 55.95 |
| 01:11 ET | 200 | 55.99 |
| 01:13 ET | 100 | 55.9 |
| 01:15 ET | 300 | 55.9745 |
| 01:18 ET | 2310 | 55.8 |
| 01:22 ET | 900 | 55.88 |
| 01:24 ET | 600 | 56.045 |
| 01:27 ET | 900 | 56.13 |
| 01:29 ET | 727 | 56.12 |
| 01:31 ET | 773 | 56.25 |
| 01:33 ET | 300 | 56.175 |
| 01:36 ET | 2242 | 56.11 |
| 01:38 ET | 200 | 56.11 |
| 01:40 ET | 1141 | 55.9651 |
| 01:42 ET | 2370 | 55.97 |
| 01:44 ET | 100 | 56 |
| 01:45 ET | 100 | 56 |
| 01:47 ET | 600 | 55.935 |
| 01:51 ET | 548 | 55.83 |
| 01:54 ET | 400 | 55.79 |
| 01:56 ET | 100 | 55.81 |
| 01:58 ET | 100 | 55.775 |
| 02:00 ET | 400 | 55.69 |
| 02:03 ET | 100 | 55.71 |
| 02:05 ET | 400 | 55.73 |
| 02:07 ET | 200 | 55.64 |
| 02:09 ET | 2516 | 55.425 |
| 02:12 ET | 500 | 55.48 |
| 02:16 ET | 520 | 55.45 |
| 02:18 ET | 399 | 55.48 |
| 02:20 ET | 600 | 55.42 |
| 02:21 ET | 700 | 55.46 |
| 02:23 ET | 200 | 55.39 |
| 02:25 ET | 1300 | 55.555 |
| 02:27 ET | 1143 | 55.63 |
| 02:30 ET | 1772 | 55.635 |
| 02:32 ET | 716 | 55.74 |
| 02:34 ET | 1400 | 55.8 |
| 02:36 ET | 1035 | 55.66 |
| 02:38 ET | 900 | 55.59 |
| 02:39 ET | 799 | 55.59 |
| 02:41 ET | 1300 | 55.62 |
| 02:43 ET | 935 | 55.45 |
| 02:45 ET | 2200 | 55.475 |
| 02:48 ET | 100 | 55.4 |
| 02:50 ET | 1184 | 55.245 |
| 02:52 ET | 1156 | 55.29 |
| 02:56 ET | 700 | 55.335 |
| 02:57 ET | 800 | 55.47 |
| 02:59 ET | 833 | 55.48 |
| 03:03 ET | 400 | 55.31 |
| 03:06 ET | 1300 | 55.385 |
| 03:08 ET | 200 | 55.385 |
| 03:10 ET | 1200 | 55.51 |
| 03:12 ET | 800 | 55.55 |
| 03:14 ET | 5720 | 55.55 |
| 03:15 ET | 3115 | 55.49 |
| 03:17 ET | 700 | 55.525 |
| 03:19 ET | 600 | 55.615 |
| 03:21 ET | 1336 | 55.73 |
| 03:24 ET | 278 | 55.77 |
| 03:26 ET | 700 | 55.78 |
| 03:28 ET | 900 | 55.83 |
| 03:30 ET | 700 | 55.83 |
| 03:32 ET | 809 | 55.76 |
| 03:33 ET | 100 | 55.765 |
| 03:35 ET | 2308 | 55.68 |
| 03:37 ET | 2569 | 55.595 |
| 03:39 ET | 600 | 55.59 |
| 03:42 ET | 500 | 55.625 |
| 03:44 ET | 1418 | 55.73 |
| 03:46 ET | 200 | 55.72 |
| 03:48 ET | 1800 | 55.74 |
| 03:50 ET | 1000 | 55.65 |
| 03:51 ET | 1335 | 55.62 |
| 03:53 ET | 800 | 55.61 |
| 03:55 ET | 6384 | 55.57 |
| 03:57 ET | 1852 | 55.58 |
| 04:00 ET | 72956 | 55.58 |
Nov 5, 2024
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition, from 9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 1, 2024
DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 12:43PM ET on Friday Nov 01, 2024 by Dow Jones
12:43PM ET on Friday Nov 01, 2024 by Dow JonesDJ Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank, from 10:30AM ET on Friday Nov 01, 2024 by Dow Jones
10:30AM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
*DJ Agios Pharmaceuticals 3Q EPS $16.22 >AGIO, from 6:30AM ET on Thursday Oct 31, 2024 by Dow Jones
6:30AM ET on Thursday Oct 31, 2024 by Dow JonesAgios Reports Business Highlights and Third Quarter 2024 Financial Results, from 6:30AM ET on Thursday Oct 31, 2024 by Dow Jones
6:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agios Pharmaceuticals Inc | 3.2B | 4.5x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Verona Pharma PLC | 3.1B | -20.0x | --- |
Merus NV | 3.0B | -11.4x | --- |
Edgewise Therapeutics Inc | 3.0B | -21.4x | --- |
Dyne Therapeutics Inc | 3.0B | -8.4x | --- |
Company Information
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Contact Information
- Headquarters
- 88 Sidney StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-649-8600
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Jacqualyn Fouse
- Chief Executive Officer, Director
- Brian Goff
- Chief Financial Officer
- Cecilia Jones
- Chief Legal Officer
- James Burns
- Chief Medical Officer, Head - Research and Development
- Sarah Gheuens
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
|---|---|
Revenue (TTM) | $32.9M |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $12.28 |
Book Value | $14.50 |
P/E Ratio | 4.5x |
Price/Sales (TTM) | 96.4 |
Price/Cash Flow (TTM) | 4.3x |
Operating Margin | 2,075.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
